Edesa Biotech Jutalékok
Mi az Edesa Biotech Jutalékok?
A Jutalékok az Edesa Biotech, Inc. - N/A
Mi a Jutalékok meghatározása?
Az osztalék mértéke az egy részvényre jutó osztalék összege, amelyet a társaság fizet a részvényeseinek egy év alatt.
The dividend rate is the total amount a company pays per share to a shareholders of its stock over a trailing one year. When the amount is calculated to be a ratio, the dividend rate identifies the dividends paid out per share. Dividends are when a company distributes a percentage of their profits to shareholders.
Mit csinál Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.